Diane S. Aschenbrenner
Abstract
Serious hepatic injury, including liver failure or death, is possible with use of the antifungal ketoconazole (Nizoral). Use of oral ketoconazole is now limited to the treatment of serious fungal disorders that haven't responded to other antifungal drugs or cases in which a patient cannot tolerate other antifungals.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Serious hepatic injury, including liver failure or death, is possible with use of the antifungal ketoconazole (Nizoral). Use of oral ketoconazole is now limited to the treatment of serious fungal disorders that haven't responded to other antifungal drugs or cases in which a patient cannot tolerate other antifungals.
Key concepts: Ketoconazole, Antifungal, Antifungal drugs, Antifungal drug, Drug, Intensive care medicine, Medicine, Liver failure